Table 2 Dosimetry comparison of OAR of AP and manP (mean ± SD).
From: Application of auto-planning in radiotherapy for breast cancer after breast-conserving surgery
OAR | n | AP | manP | t | P-value |
|---|---|---|---|---|---|
Ipsilateral lung | |||||
V20 (%) | 30 | 10.83 ± 3.70 | 11.67 ± 3.74 | 14.75 | < 0.01 |
V10 (%) | 30 | 15.9 ± 4.25 | 17.61 ± 4.33 | 18.6 | < 0.01 |
V5 (%) | 30 | 22.26 ± 4.78 | 24.73 ± 5.10 | 3.61 | < 0.05 |
Dmean (cGy) | 30 | 603.56 ± 166.41 | 642.33 ± 168.08 | 16.56 | < 0.01 |
Contralateral lung | |||||
Dmean (cGy) | 30 | 18.73 ± 3.44 | 19.10 ± 3.57 | 5.88 | < 0.01 |
Heart of all patients | |||||
V40 (%) | 30 | 0.53 ± 0.88 | 0.58 ± 0.96 | 2.64 | < 0.05 |
V30 (%) | 30 | 0.87 ± 1.35 | 1.12 ± 1.95 | 1.6 | 0.12 |
Dmean (cGy) | 30 | 149.02 ± 122.22 | 170.19 ± 134.87 | 4.07 | < 0.01 |
Heart of patients with left breast cancer | |||||
V40 (%) | 12 | 1.34 ± 0.95 | 1.46 ± 1.01 | 3.22 | < 0.01 |
V30 (%) | 12 | 2.18 ± 1.30 | 2.81 ± 2.20 | 1.67 | 0.12 |
Dmean (cGy) | 12 | 282.50 ± 77.07 | 318.63 ± 80.87 | − 7.88 | < 0.01 |
Contralateral breast | |||||
Dmax (cGy) | 30 | 294.45 ± 232.48 | 320.46 ± 246.24 | 0.86 | 0.4 |
